Australia markets open in 9 hours 13 minutes

    -29.60 (-0.39%)

    +0.0019 (+0.27%)
  • ASX 200

    -20.10 (-0.28%)
  • OIL

    +1.96 (+2.96%)
  • GOLD

    +13.50 (+0.76%)

    -980.40 (-1.20%)
  • CMC Crypto 200

    +37.22 (+2.58%)

Gastroesophageal Reflux Disease Devices Market Research Report - Global Forecast to 2026 - Cumulative Impact of COVID-19

·6-min read

Gastroesophageal Reflux Disease Devices Market Research Report by Product Type (Diagnostic Devices, Esophagoscopes and Gastroscopes, and Fundoplication Devices), by Procedure Type (Diagnostic Procedures, Fundoplication Procedures, and Magnetic Sphincter Augmentation), by Device Type, by Surgery Type, by Route of Administration, by Dosage Form, by End-User, by Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2026 - Cumulative Impact of COVID-19

New York, Oct. 18, 2021 (GLOBE NEWSWIRE) -- announces the release of the report "Gastroesophageal Reflux Disease Devices Market Research Report - Global Forecast to 2026 - Cumulative Impact of COVID-19" -

The Global Gastroesophageal Reflux Disease Devices Market size was estimated at USD 4,022.73 million in 2020 and expected to reach USD 4,550.91 million in 2021, at a CAGR 13.46% to reach USD 8,585.61 million by 2026.

Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:
This research report categorizes the Gastroesophageal Reflux Disease Devices to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product Type, the market was studied across Diagnostic Devices, Esophagoscopes and Gastroscopes, Fundoplication Devices, Manometry System, PH Monitoring System, Radiofrequency Ablation Devices, Sphincter Augmentation Devices, Treatment Devices, and Ultrasonic Surgical Endostapler.

Based on Procedure Type, the market was studied across Diagnostic Procedures, Fundoplication Procedures, Magnetic Sphincter Augmentation, and Radiofrequency Thermal Ablation.

Based on Device Type, the market was studied across Bravo Reflux Testing System, Digitrapper reflux testing system, LINX Management System, MUSE –Medigus Ultrasonic Surgical Endostapler, Others, and Stretta Therapy.

Based on Surgery Type, the market was studied across Invasive and Non-invasive. The Invasive is further studied across Linx Reflux Management and Medigus Ultrasonic Surgical Endostapler. The Non-invasive is further studied across Endocinch Endolumminal gastroplication, Endoscopic Plicator System, EsophyX, Plexiglas poly-methyl-methacrylate (PMMA) microspheres, and Stretta.

Based on Route of Administration, the market was studied across Oral and Parenteral.

Based on Dosage Form, the market was studied across Liquid and Solid.

Based on End-User, the market was studied across Government, Hospitals, Medical Practitioners, and Others.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Gastroesophageal Reflux Disease Devices Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Gastroesophageal Reflux Disease Devices Market, including Addex Pharmaceuticals Ltd., Aros Pharma ApS, AstraZeneca Plc, C. R. Bard, Inc.,, Eisai Co., Ltd, EndoGastric Solutions, Inc., KARL STORZ SE & Co. KG, MediGus Ltd., Olympus Corporation, PENTAX Medical (Global), Pfizer Inc., Takeda Pharmaceutical Company Limited, and The Procter & Gamble Company.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Gastroesophageal Reflux Disease Devices Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Gastroesophageal Reflux Disease Devices Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Gastroesophageal Reflux Disease Devices Market?
4. What is the competitive strategic window for opportunities in the Global Gastroesophageal Reflux Disease Devices Market?
5. What are the technology trends and regulatory frameworks in the Global Gastroesophageal Reflux Disease Devices Market?
6. What is the market share of the leading vendors in the Global Gastroesophageal Reflux Disease Devices Market?
7. What modes and strategic moves are considered suitable for entering the Global Gastroesophageal Reflux Disease Devices Market?
Read the full report:

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.


CONTACT: Clare: US: (339)-368-6001 Intl: +1 339-368-6001

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting